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Foxp3+ regulatory T (Treg) cells, which suppress im-
mune responses, are highly proliferative in vivo.
However, it remains unclear how the active replica-
tion of Treg cells is maintained in vivo. Here, we
show that branched-chain amino acids (BCAAs),
including isoleucine, are required for maintenance
of the proliferative state of Treg cells via the
amino acid transporter Slc3a2-dependent metabolic
reprogramming. Mice fed BCAA-reduced diets
showed decreased numbers of Foxp3+ Treg cells
with defective in vivo proliferative capacity. Mice
lacking Slc3a2 specifically in Foxp3+ Treg cells
showed impaired in vivo replication and decreased
numbers of Treg cells. Slc3a2-deficient Treg cells
showed impaired isoleucine-induced activation of
the mTORC1 pathway and an altered metabolic
state. Slc3a2 mutant mice did not show an isoleu-
cine-induced increase of Treg cells in vivo and ex-
hibited multi-organ inflammation. Taken together,
these findings demonstrate that BCAA controls
Treg cell maintenance via Slc3a2-dependent meta-
bolic regulation.
INTRODUCTION
Naturally occurring regulatory T (Treg) cells that express the tran-
scription factor Foxp3 play a mandatory role in the maintenance1824 Cell Reports 21, 1824–1838, November 14, 2017 ª 2017 The A
This is an open access article under the CC BY-NC-ND license (http://of self-tolerance and prevention of autoimmunity (Sakaguchi,
2000;Wing and Sakaguchi, 2010). Treg cells are hyporesponsive
to T cell receptor (TCR) stimulation in vitro. However, Treg cells
are highly proliferative in vivo and highly express several T cell
activation markers (Fisson et al., 2003; Vukmanovic-Stejic
et al., 2006). The defective proliferation of Treg cells in vivo has
been shown to correlate with autoimmune diseases in humans
(Carbone et al., 2014). Thus, preservation of the in vivo replicative
capacity of Treg cells is required for the maintenance of immune
homeostasis. Interleukin-2 (IL-2) mediates the survival and pro-
liferation of Treg cells in vivo (Sakaguchi et al., 2006). However,
the proliferation of Treg cells is not induced by IL-2 in vitro, indi-
cating the presence of unidentified environmental factors
responsible for the in vivo maintenance of Treg cells.
Activated T cells are highly proliferative and undergo in-
creased protein synthesis. Accordingly, activated T cells,
including Treg cells, are metabolically regulated bymechanisms,
including the enhanced uptake of amino acids (Newton et al.,
2016). Several lines of evidence have indicated that amino acids,
especially branched-chain amino acids (BCAAs), are required for
maintaining the high metabolic status of activated T cells. Lym-
phocytes were shown to have the highest incorporation of
isoleucine compared with eosinophils and neutrophils (Burns,
1975). Animals fed diets containing reduced valine, isoleucine,
or leucine showed defective antibody responses or cytotoxic
T cell responses (Calder, 2006; Jose and Good, 1973; Tsukishiro
et al., 2000). Foxp3+ Treg cells are highly activated in vivo; how-
ever, the requirement for amino acids to maintain Treg cells re-
mains poorly understood.
Amino-acid-mediated cellular activation involves activation of






Figure 1. Decreased Number of Splenic Foxp3+ Treg Cells in Mice Fed a BCAA-Reduced Diet
(A) Frequency and cell number of splenic Foxp3+ CD4+ T cells in mice fed a control or the indicated BCAA-reduced diet. Representative dot plots (upper),
percentage (bottom left), and total cell number (bottom right) of Foxp3+ CD4+ T cells are shown (n = 5 per group). p values were determined by Tukey-Kramer test.
**p < 0.01; ***p < 0.005; ****p < 0.001.
(B) Frequency of Foxp3+CD4+ T cells in the small intestine (SI) and the large intestine (LI) of the control or isoleucine-reduced diet groups. Representative dot plots
(left) and percentage (right) of Foxp3+ CD4+ T cells are shown (n = 5 per group).
(C) Cell number of Foxp3+ CD4+ T cells in the SI and the LI of the control (n = 6) or isoleucine-reduced diet groups (n = 5 or 6) are shown.
(D) Total cell number of CD4+ T cells in the lamina propria of the LI (n = 6 per group) and the SI (n = 5 or 6) in BALB/cmice fed control or isoleucine-reduced diet for
2 weeks.
(legend continued on next page)
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mediates multiple cellular functions, including proliferation
(Appuhamy et al., 2012; Laplante and Sabatini, 2012). mTOR
forms two distinct complexes named mTORC1 and mTORC2,
of which mTORC1 is activated by amino acids. The mTOR
pathway is involved in several Treg cell functions as well as the
differentiation of helper T (Th) cells (Chi, 2012; Procaccini and
Matarese, 2012; Thomson et al., 2009). The transient stimulation
of mTOR via the TCR and CD28 induced Foxp3 expression in
T cells, but continuous stimulation led to a blockade of Foxp3
expression (Sauer et al., 2008). Similarly, the constitutive activa-
tion of mTOR by AKT inhibited Foxp3 expression in T cells (Hax-
hinasto et al., 2008). Control of Treg cell differentiation by mTOR
was also demonstrated in mice with a T-cell-specific deletion of
mTOR (Delgoffe et al., 2009). Thus, themTOR pathway regulates
Foxp3+ Treg cell differentiation. The in vivo expansion of Treg
cells has also been shown to be controlled by mTOR. Inhibition
of the mTOR pathway by rapamycin resulted in the expansion
of Foxp3+ Treg cells in mice (Battaglia et al., 2005). A subsequent
analysis of human Treg cells showed that the activation of mTOR
inhibited Treg cell proliferation at early time points, but at later
time points, it is required for sustained Treg cell proliferation
over time (Procaccini et al., 2010). Thus, the oscillatory activity
of mTOR controls the proliferation of Treg cells. Furthermore,
the function and proliferation of Treg cells are controlled by
mTORC1 through the promotion of biosynthesis (Zeng and
Chi, 2015; Zeng et al., 2013). In addition, impaired suppressive
functions of Treg cells were reported in mice with a T-cell-spe-
cific ablation of Tsc1, a key upstream regulator of mTORC1
(Park et al., 2013). Thus, multiple Treg cell functions are regu-
lated by the mTOR pathway.
In line with the fact that the amino acid/mTOR axis regulates
Th cell differentiation (Chi, 2012), transporters of amino acids,
particularly Slc7a5 (also called L-type amino acid transporter 1
[Lat1]), that preferentially incorporate large neutral amino acids
(LNAAs), were shown to be critical for the development of Th1
and Th17 cells (Sinclair et al., 2013). Slc7a5/Lat1 interacts with
Slc3a2 (also called CD98 heavy chain [CD98hc]) to form the
LNAA transporter (Kanai et al., 1998). Slc3a2/CD98hc is manda-
tory for the expansion of T cells as well as the differentiation of
Th1 and Treg cells (Bhuyan et al., 2014; Cantor et al., 2011; Kur-
ihara et al., 2015). However, it remains unclear whether the LNAA
transporter, which mediates amino-acid-dependent activation
of the mTOR pathway, regulates Treg cell proliferation and
maintenance.
In this study, we analyzed the role of BCAA, particularly isoleu-
cine, and Slc3a2 for the in vivomaintenance of Foxp3+ Treg cells.
Mice fed diets reduced in isoleucine, leucine, or valine showed
reduced numbers of Foxp3+ Treg cells in the periphery. The
in vivo proliferation and suppressive ability of Treg cells were
reduced in mice fed diets with reduced isoleucine. Isoleucine
induced activation of the mTORC1 pathway in Foxp3+, but not
Foxp3 CD4+ T cells. Foxp3+ Treg cells expressed high levels
of Slc3a2, which comprises the transporter complex that medi-(E) Frequency among CD4+ T cells (upper) and total cell number (bottom) of sple
control or isoleucine-reduced diet for 2 weeks (n = 5 per group).
In graphs, each symbol represents an individual mouse, and the means ± SD are
*p < 0.05; **p < 0.01. DIle, isoleucine-reduced diet; DLeu, leucine-reduced diet;
1826 Cell Reports 21, 1824–1838, November 14, 2017ates isoleucine incorporation. Treg cells from mice lacking
Slc3a2 specifically in Foxp3+ cells showed decreased cell
numbers, reduced proliferative activity, impaired isoleucine re-
sponses, and altered metabolic program. The mutant mice
also showed defects in the suppressive activity of Treg cells
and inflammatory changes in multiple organs. Thus, the BCAA/
Slc3a2 axis is required for the maintenance of highly proliferative
Treg cells in the periphery.
RESULTS
Reduced Numbers of Foxp3+ Treg Cells in Mice Fed a
Reduced BCAA Diet
In order to analyze the effect of BCAA for the in vivomaintenance
of Treg cells, we fed 6-week-old BALB/c mice a diet reduced in
valine (DVal), leucine (DLeu), or isoleucine (DIle) (10% of the stan-
dard amount) for 2 weeks. Then, we analyzed the frequency and
number of Foxp3+ CD4+ cells as well as interferon (IFN)-g+, IL-
17+, or IL-10+ CD4+ T cells in the spleen by flow cytometry (Fig-
ures 1A and S1). The frequency and number of IFN-g-, IL-17-, or
IL-10-producing CD4+ T cells were not altered in mice fed diets
with reduced amounts of any BCAA. However, the frequency
and number of Foxp3+ CD4+ T cells were decreased in mice
fed diets with reduced BCAA. Especially, mice fed diet contain-
ing reduced Ile showed the most severe reduction in the number
of Foxp3+ CD4+ T cells. Therefore, we analyzed the effect of Ile in
the subsequent experiments. We analyzed the frequency and
number of Foxp3+ CD4+ T cells and innate immune cell popula-
tions in the lamina propria of the small and large intestines (Fig-
ures 1B, 1C, and S2A). The frequency and number of Foxp3+
CD4+ T cells in these tissues were decreased in mice fed Ile-
reduced diet, although total CD4+ T cell number and innate
myeloid cell populations in the intestine were not altered (Fig-
ure 1D). Because activated T cells require more amino acids
than resting naive T cells, we analyzed the frequency and num-
ber of CD44high CD62Llow effector CD4+ T cells and CD44low
CD62Lhigh naive CD4+ T cells in mice fed Ile-reduced diet
(Figure 1E). The number of CD44high CD62Llow effector CD4+
T cells was not reduced in mice fed Ile-reduced diet. The number
of Foxp3+ CD4+ T cells in thymus was not decreased in mice fed
Ile-reduced diet (Figure S2B). Thus, the number of Foxp3+ CD4+
Treg cells in the periphery was selectively diminished in mice fed
Ile-reduced food. Serum concentrations of Ile were selectively
decreased among several amino acids analyzed in mice fed
Ile-reduced diet, although concentrations of histidine and
phenylalanine were slightly increased (Figure S3). Thus, the
decreased number of Foxp3+ CD4+ Treg cells in the periphery
correlated with the decreased serum concentration of Ile.
Defective In Vivo Proliferation of Foxp3+ Treg Cells in
Mice Fed a Reduced Isoleucine Diet
We analyzed whether Ile is required for Treg cell differentiation.
Naive CD4+ T cells were cultured in the presence of transformingnic CD44high CD62Llow or CD44low CD62Lhigh T cell subset in BALB/c mice fed
shown by horizontal bars. p values were determined by Mann-Whitney U test.






Figure 2. Impaired Proliferation of Foxp3+ Treg Cells by Isoleucine Insufficiency
(A) Representative histograms (left) and frequency (right) of TUNEL+ cells among CD25+ CD4+ cells in the control or isoleucine-reduced diet groups (n = 5 per
group).
(B) Representative fluorescence-activate cell sorting (FACS) dot plots (left) and frequency (right) of annexin V+ 7-AAD and annexin V+ 7-AAD+ cells amongCD25+
CD4+ cells in the control or isoleucine-reduced diet groups (n = 5 per group).
(C) Representative histograms (left) and frequency (right) of BrdU+ cells among the indicated cells in mice given a control or isoleucine-reduced diet (n = 5 per
group).
(legend continued on next page)
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growth factor b (TGF-b) to induce Treg cells in media with or
without Ile (Figure S4A). Foxp3+ Treg cells were similarly induced
in both conditions, indicating that Ile is not involved in the Treg
cell differentiation.
We next analyzed whether Treg cells are prone to death in the
absence of Ile. BALB/c mice were fed Ile-reduced or control diet
for 2 weeks, and splenocytes were analyzed by terminal deoxy-
nucleotidyl transferase deoxyuridine triphosphate (dUTP) nick
end labeling (TUNEL) assay (Figure 2A). TUNEL-positive cells
were not increased in the population of CD25+ CD4+ Treg cells
from mice fed Ile-reduced diet. Splenocytes were also stained
with annexin V and 7-amino-actinomycin D (7-AAD) to detect
early (annexin V+ 7-AAD) and late (annexin V+ 7-AAD+) apoptotic
cells (Figure 2B). Annexin-V-positiveCD25+CD4+Treg cellswere
not increased in mice fed Ile-reduced diet. We then isolated
Foxp3+CD4+ T cells and cultured them in control and Ile-freeme-
dia for 6 hr. The number of annexin V+ 7-AAD and annexin V+
7-AAD+ cells was not altered between control and Ile-free media
(Figure S4B). Thus, the Ile insufficiency did not lead to the
increased death of CD25+ Treg cells. Next, we analyzed the
in vivo proliferative capacity of Foxp3+ CD4+ Treg cells by
measuring bromodeoxyuridine (BrdU) incorporation and Ki67
staining (Figures 2C and 2D). BrdU incorporation was markedly
increased in splenic Foxp3+ CD4+ cells compared with Foxp3
CD4+ cells, and the BrdU uptake was severely reduced in
Foxp3+ CD4+ cells frommice fed Ile-reduced diet. The frequency
of Ki67-positive Foxp3+ CD4+ cells was also decreased in mice
fed Ile-reduced diet compared to those fed control diet. A reduc-
tion in the proliferative capacity of the Ile-reduced diet groupwas
specific to Foxp3+CD4+ cells, because the numbers of Ki67-pos-
itive cells were unaltered in the Foxp3 CD44high CD62Llow
effector CD4+ T cell population and Foxp3 CD44low CD62Lhigh
naive CD4+ T cell population. We then transferred carboxy-
fluorescein succinimidyl ester (CFSE)-labeled CD62Llow CD4+
effector T cells into severe combined immunodeficiency (SCID)
mice fed control or Ile-reduced diet. At 5 days after the transfer,
CFSE intensity was analyzed in Foxp3+ and Foxp3 populations
of transferred CD62Llow CD4+ T cells (Figure 2E). In the Foxp3+
population, the percentage of reducedCFSE intensity wasmark-
edly decreased. In contrast, CFSE intensity was similar in Ile-suf-
ficient and -reduced conditions in the Foxp3 population. Thus,
during the Ile-insufficient condition, Foxp3+ Treg cells showed
a reduced proliferation in vivo, possibly causing a decrease in
the number of Treg cells in the periphery.
mTOR-Dependent Maintenance of Foxp3+ Treg Cell
Functions
Amino acids activate the mTOR pathway (Laplante and Sabatini,
2012; Proud, 2007). In addition, themTOR signaling pathway has(D) Representative histograms (left) and frequency (right) of Ki67+ cells among th
group).
(E) SCID mice fed control or isoleucine-reduced diet were intraperitoneally transfe
transfer, splenic Foxp3+ CD4+ (Foxp3+) and Foxp3 CD62Llow CD4+ (Foxp3)
frequency (right) of non-dividing CFSE+ cells among Foxp3+ CD4+ and Foxp3 C
group) are shown.
In graphs, each symbol represents an individual mouse, and the means ± SD are
*p < 0.05; **p < 0.01.
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cini et al., 2010; Thomson et al., 2009; Zeng et al., 2013). There-
fore, we next analyzed the Ile- or Leu-induced activation of the
mTOR pathway by detecting the phosphorylation of S6 ribo-
somal protein (S6) and p70 S6 kinase (p70S6K), which are
activated downstream of mTORC1. First, we analyzed the phos-
phorylation of p70S6K of splenic Foxp3+ Treg cells in mice fed
control or Ile-reduced diet (Figure 3A). In control-diet-fed
mice, p70S6K was highly phosphorylated. However, the level
of p70S6K phosphorylation was markedly decreased in mice
fed Ile-reduced diet. Next, Foxp3+ and Foxp3 CD4+ cells
were isolated from the spleen of mice fed standard diets,
cultured for 12 hr in amino-acid-free media, and then stimulated
with Ile or Leu for 20 min. After 12 hr of culture in the absence of
amino acids, the phosphorylation level of S6 was markedly
decreased. However, Ile and Leu induced the phosphorylation
of S6 in Foxp3+ CD4+ cells, but not in Foxp3 CD4+ cells (Fig-
ure 3B). The phosphorylation of p70S6K was also induced in
Foxp3+ CD4+ cells, but not in Foxp3 CD4+ cells, by Ile and
Leu (Figure 3C). The majority of Foxp3 CD4+ cells are resting
naive T cells. Therefore, we analyzed Ile-mediated phosphoryla-
tion of S6 in Foxp3 CD44high CD62Llow CD4+ effector T cells
(Figure 3D). In this experiment, cells starved in an amino-acid-
free medium were stimulated with a full medium (containing
essential amino acids) or an Ile-free medium (containing essen-
tial amino acids, but not Ile). The full medium induced the phos-
phorylation of S6 both in Foxp3+ and Foxp3 effector T cells. In
contrast, the Ile-free medium failed to induce the phosphoryla-
tion of S6 in Foxp3+ cells but induced the phosphorylation of
S6 in Foxp3 effector T cells. Thus, Ile is required for the phos-
phorylation of S6 in Foxp3+ cells, but not in Foxp3 effector
T cells. This result also indicates that mTOR activation in Foxp3
effector T cells was induced in an Ile-independent manner. The
phosphorylation of S6 in Foxp3+ CD4+ cells was sustained after
12 hr of culture in the presence of Ile or Leu (Figure 3E). These
findings indicate that Ile and Leu activate the mTOR pathway
in Foxp3+ Treg cells. Because mTORC1 has been shown to
regulate the expression of surface molecules, such as cytotoxic
T-lymphocyte antigen 4 (CTLA-4) (Zeng et al., 2013), we
analyzed the expression of CTLA-4 and glucocorticoid-induced
TNF receptor-related protein (GITR) on Foxp3+ Treg cells of mice
fed Ile-reduced diets (Figure 3F). The surface expressions of
CTLA-4 and GITR on Foxp3+ CD4+ cells in the spleen were
severely reduced in mice fed Ile-reduced diet compared to
mice fed control diet. Because these molecules are required
for Treg cell function, we analyzed the suppressive ability of
CD25+ CD4+ cells in the spleen of mice fed Ile-reduced diet.
CD25CD4+ T cells were cultured with dendritic cells and
anti-CD3 antibody in the presence of various numbers ofe indicated cells in mice given a control or isoleucine-reduced diet (n = 5 per
rred with CFSE-labeled CD62Llow CD4+ cells from BALB/c. At 5 days after the
cells were analyzed by flow cytometry. Representative histograms (left) and
D62Llow CD4+ cells in mice given control or isoleucine-reduced diet (n = 4 per








Figure 3. Isoleucine-Dependent Activation of mTOR Signaling in Foxp3+ Treg Cells
(A) Phospho-p70 S6K (Thr389) of splenic Foxp3+ CD4+ Treg cells fromBALB/cmice fed control or isoleucine-reduced diet were analyzed by flow cytometry. Gray
histogram shows the isotype control.
(B and C) Foxp3+ CD4+ cells (left) and Foxp3 CD4+ cells (right), cultured for 12 hr without amino acids, were stimulated with 5 mM isoleucine (solid lines), 5 mM
leucine (dotted lines), or PBS (gray histograms) for 20min and analyzed for phospho-S6 (P-S6) (B) and phosphor-p70S6K (P-p70S6K) (C). Data are representative
of three independent experiments.
(D) Splenic Foxp3+ CD4+ cells (left) and Foxp3CD44high CD62Llow CD4+ cells (right) from Foxp3-GFPmice were cultured without essential amino acids for 12 hr
and then stimulated with full medium (solid line), isoleucine-free medium (dotted line), or essential amino acids (EAAs)-free medium (gray histogram) with 10%
dialyzed fetal bovine serum (FBS), 5 mg/mL anti-CD3 antibody, and 5 mg/mL anti-CD28 antibody for 20min. The cells were analyzed for phospho-S6 (P-S6) by flow
cytometry.
(E) The cells were cultured for 12 hr in the presence of 5 mM isoleucine (solid line), 5 mM leucine (dotted line), or PBS (gray histogram) and analyzed for phosphor-
S6 (P-S6). Data are representative of three independent experiments.
(legend continued on next page)
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CB
Figure 4. High Sensitivity to Intestinal
Inflammation of Mice Fed an Isoleucine-
Reduced Diet
(A) Bodyweight change (percent of initial weight) of
control-diet-fed mice (closed circle; n = 17) or
isoleucine-reduced-diet-fed mice (open circle;
n = 16) per group. Data are the means ± SEM.
p values were determined by Student’s t test.
(B) H&E staining of colon sections without DSS ()
and after DSS administration on day 9. The scale
bars represent 100 mm.
(C) Histological score of colonic inflammation of
control-diet-fed mice (closed circle) or isoleucine-
reduced-diet-fed mice (open circle; n = 4 per
group) on day 9.
In graphs, each symbol represents an individual
mouse and means ± SD are shown by horizontal
bars. p values were determined by Student’s t test.
*p < 0.05; **p < 0.01; ***p < 0.005.CD25+ CD4+ cells from mice fed Ile-reduced diet or control diet
(Figure 3G). The suppression of T cell proliferation was impaired
by the deprivation of Ile. Taken together, these findings indicate
that the BCAA/mTORC1 pathway regulates the maintenance
and function of Foxp3+ Treg cells in the periphery.
The dysregulation of Treg cells leads to inflammatory disor-
ders, including intestinal inflammation (Singh et al., 2001). How-
ever, after 2 weeks of feeding with Ile-reduced diet, mice did
not show any obvious inflammatory changes. Therefore, we
analyzed whether mice fed Ile-reduced diet were sensitive to
dextran sodium sulfate (DSS)-induced intestinal inflammation.
The DSS treatment of mice fed Ile-reduced diet resulted in
severe intestinal inflammation characterized by pronounced
weight loss and severe pathological changes of the colon
compared with mice fed control diets (Figures 4A–4C). Thus,
Ile insufficiency in diets resulted in high sensitivity to intestinal
inflammation.
High Expression of Slc3a2 in Foxp3+ Treg Cells
In order to analyze the mechanisms by which Ile and Leu control
Treg cell homeostasis, we analyzed the expression of genes
encoding molecules that mediate the transport of BCAAs. These
included L-type amino acid transporters (Lat1–4) and system y+(F) Expression of CTLA-4 and GITR on splenic Foxp3+ CD4+ Treg cells in mice fed a control (solid line) or isoleu
represents the isotype control.
(G) [3H]-thymidine uptake by CD25 CD4+ T cells co-cultured with dendritic cells in the presence of increasi
mice fed a control (closed circle) or isoleucine-reduced (open circle) diet.
Data are the means ± SD of triplicate well measurements and representative of three independent experime
*p < 0.05. DEAA, essential amino-acid-free medium; DIle, isoleucine-free medium (D) or isoleucine-reduce
isoleucine; Leu, leucine.
1830 Cell Reports 21, 1824–1838, November 14, 2017L-type amino acid transporters (y+Lat1
and 2), Slc6a14 and Slc6a19 (Bodoy
et al., 2005; Bröer et al., 2004; Ganapathy
and Ganapathy, 2005; Kanai et al., 1998;
Verrey et al., 2004). Because many of
these molecules (Lat1 and 2 and y+Lat1
and 2) associate with Slc3a2/CD98hc toform the transporter complex, we also analyzed the expression
of Slc3a2 (Figure 5A). The expression of several genes, including
Slc7a5 (encoding Lat1) and Slc43a2 (encoding Lat4), was
enhanced in Foxp3+ CD4+ cells compared to Foxp3 CD4+ cells
from the spleen. In particular, the expression of Slc3a2 was
markedly higher in Foxp3+ CD4+ cells than Foxp3 CD4+ cells.
We also analyzed protein expression of Slc3a2 (CD98hc) on
Foxp3+ CD4+ cells, Foxp3 CD44high CD62Llow effector CD4+
T cells, and Foxp3 CD44low CD62Lhigh naive CD4+ T cells by
flow cytometry (Figure 5B). Slc3a2 expression was the highest
in Foxp3+ CD4+ cells. Thus, expression of subunits of amino
acid transporters, Slc7a5, Slc43a2, and especially Slc3a2, was
enhanced in Foxp3+ Treg cells.
Decreased Numbers of Foxp3+ Treg Cells in
Treg-Cell-Specific Slc3a2-Deficient Mice
To analyze the role of Slc3a2 in Treg cells homeostasis, we
generated mice lacking Slc3a2 specifically in Foxp3+ Treg cells
(Foxp3cre; Slc3a2flox/flox; Figure S5A). The frequency of Foxp3+
CD4+ cells in the spleen of Foxp3cre; Slc3a2flox/flox mice was
markedly decreased (Figure 5C). We further analyzed the per-
centage and number of Foxp3+ CD44lowCD62Lhigh resting Treg
cells and Foxp3+ CD44highCD62Llow activated Treg cells in thecine-reduced diet (dotted line). The gray histogram
ng ratios of splenic CD25+ CD4+ cells derived from
nts. p values were determined by Student’s t test.
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Figure 5. Decreased Number of Foxp3+ Treg Cells in Treg-Cell-Specific Slc3a2-Deficient Mice
(A) qRT-PCR analysis of the indicated amino acid transporter in splenic Foxp3+ CD4+ (closed bar) and Foxp3CD4+ T cells (open bar). Data are themeans ±SD of
triplicate samples in one experiment and representative of three independent experiments. p values were determined by Student’s t test. **p < 0.01; ***p < 0.005.
(B) Expression of CD98hc on splenic Foxp3+ CD4+ cells (red), Foxp3 CD44lowCD62Lhigh cells (blue), and Foxp3 CD44highCD62Llow cells (green) from Foxp3-
GFP mice was analyzed by flow cytometry. CD98hc, CD98 heavy chain.
(legend continued on next page)
Cell Reports 21, 1824–1838, November 14, 2017 1831
spleen of control and Foxp3cre; Slc3a2flox/flox mice (Figure 5D).
The numbers of both activated and resting Treg cells were
reduced in Foxp3cre; Slc3a2flox/flox mice. We then analyzed the
number of Foxp3+ Treg cells in the large intestine (Figure 5E).
The number of Foxp3+ Treg cells was reduced in the large intes-
tine of Foxp3cre; Slc3a2flox/flox mice. In the large intestine, there
exist two types of Foxp3+ Treg cells: Helios+ thymus-derived
Treg (tTreg) cells and Helios peripheral Treg (pTreg) cells.
Therefore, we analyzed which type of Treg cells was affected
by the Slc3a2 deficiency (Figure 5F). The number of Helios+ tTreg
cells was not altered in the large intestine of Foxp3cre;
Slc3a2flox/flox mice. In contrast, pTreg cell number was reduced
in the large intestine of Foxp3cre; Slc3a2flox/flox mice. The number
of Foxp3+ CD4+ T cells in thymus was not altered in Foxp3cre;
Slc3a2flox/flox mice (Figure S5B). In Foxp3cre; Slc3a2flox/flox
mice, the number of IFN-g-, IL-17-, or IL-10-producing CD4+
T cells was not altered (Figure S5C). Next, we analyzed the in vivo
proliferative ability of Foxp3+ Treg cells by measuring BrdU
incorporation and found that BrdU uptake was decreased in
Foxp3+ CD4+ cells, but not Foxp3 CD4+ cells, in the spleen of
Foxp3cre; Slc3a2flox/flox mice (Figure 5G). Thus, Foxp3+ Treg cells
showed decreased numbers and reduced proliferation in the
absence of Slc3a2. These findings suggest that Slc3a2 is
required for the maintenance of Foxp3+ Treg cells by supporting
their in vivo proliferative ability.
Impaired Ile Response of Treg Cells in
Treg-Cell-Specific Slc3a2-Deficient Mice
We next analyzed whether the decreased number of Foxp3+
Treg cells in Foxp3cre; Slc3a2flox/flox mice correlated with defec-
tive Ile responses. CD25+ CD4+ T cells, which mainly contain
Foxp3+ Treg cells, and CD25 CD4+ T cells were isolated from
the spleens of control and Foxp3cre; Slc3a2flox/flox mice and
cultured for 12 hr in amino-acid-free media. These cells were
then stimulated with Ile or Leu for 20 min and analyzed for the
phosphorylation of S6 (Figure 6A). The Ile- or Leu-mediated
phosphorylation of S6 was not induced in CD25+ CD4+ T cells
from Foxp3cre; Slc3a2flox/flox mice. We next analyzed in vivo Ile
responses by feeding control and Foxp3cre; Slc3a2flox/flox mice
Ile-reduced diets for 7 days. In control mice fed an Ile-reduced
diet, the number of Foxp3+ Treg cells was reduced and became
comparable to that in Foxp3cre; Slc3a2flox/flox mice fed with Ile-
reduced diet. These mice were reared with an Ile-sufficient
or -reduced diet for another 7 days, and the frequency of
Foxp3+ Treg cells in the spleen was analyzed (Figure 6B). In con-
trol mice, Ile supplementation increased the number of Foxp3+(C) Representative dot plots (left), frequency (upper right), and cell number (lower r
Foxp3cre; Slc3a2flox/flox mice.
(D) Frequency (upper) and cell number (lower) of CD44lowCD62Lhigh resting Treg (le
of Slc3a2flox/flox and Foxp3cre; Slc3a2flox/flox mice (n = 8 per group).
(E) Representative dot plots (left), frequency (upper right), and cell number (lowe
Slc3a2flox/flox and Foxp3cre; Slc3a2flox/flox mice.
(F) Frequency among CD4+ T cells (upper) and cell number (lower) of Helios+ Fo
Slc3a2flox/flox and Foxp3cre; Slc3a2flox/flox mice (n = 5 per group).
(G) Representative histograms and frequency of BrdU+ cells in Foxp3+ CD4+ T ce
Slc3a2flox/flox mice (n = 5 per group).
In graphs, each symbol represents an individual mouse and the means ± SD are
*p < 0.05; **p < 0.01; ***p < 0.005.
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cells in the spleen of Foxp3cre; Slc3a2flox/flox mice. Thus, the Ile
response of Foxp3+ Treg cells was abolished in the absence of
Slc3a2. We also analyzed in vivo Leu responses (Figure S6A).
Mice were fed a Leu-reduced diet for 7 days and then fed a
Leu-sufficient diet or -reduced diet for another 7 days. In
Slc3a2flow/flox mice, Leu supplementation increased the number
of Foxp3+ Treg cells in the spleen. However, Leu-mediated in-
crease of Foxp3+ Treg cells was not observed in Foxp3cre;
Slc3a2flox/flox mice, indicating that the Leu-mediated response
was also dependent on Slc3a2.
Because Slc3a2mediates the uptake of BCAAs, wemeasured
intracellular concentration of Ile, Leu, and Val in CD25+ CD4+ and
CD25 CD4+ cells of Slc3a2flox/flox and Foxp3cre; Slc3a2flox/flox
mice (Figure 6C). Concentration of these BCAAs in CD25
CD4+ cells was not altered between control and Foxp3cre;
Slc3a2flox/flox mice, rather somewhat increased in Foxp3cre;
Slc3a2flox/flox mice. Notably, concentration of Ile was higher
in CD25+ CD4+ cells than CD25 CD4+ cells of control
(Slc3a2flox/flox) mice. Furthermore, Ile concentration was
decreased in CD25+ CD4+ cells of Foxp3cre; Slc3a2flox/flox mice
compared to control mice, although concentration of Val
and Leu was not altered. We also analyzed Ile uptake by
splenic CD25+ CD4+ Treg cells of Slc3a2flox/flox and Foxp3cre;
Slc3a2flox/flox mice (Figure 6D). Ile uptake by Slc3a2/ Treg cells
was decreased. Taken together, these findings indicate that Treg
cells preferentially uptake Ile via Slc3a2.
Slc3a2 has also been shown to mediate integrin signaling to
control migration, survival, and proliferation of cells (Fenczik
et al., 1997; Feral et al., 2005; Suga et al., 2001). Therefore, we
analyzed the b2-integrin (LFA-1)/ICAM-1-dependent adhesion
of Slc3a2/ Treg cells (Figure S6B). Slc3a2/ Treg cells bound
to ICAM-1 to a level comparable to control Treg cells. This bind-
ing was abrogated by addition of blocking antibody against
LFA-1 (Figure S6C), indicating that the Slc3a2 deficiency in
Treg cells did not affect the integrin-mediated cell adhesion.
Because mTORC1 regulates the metabolic program of T cells,
we analyzed whether Slc3a2/ Treg cells displayed an altered
metabolic status. The extracellular acidification rate (ECAR),
which reflects aerobic glycolysis, was measured in CD25+
CD4+ T cells isolated from the spleen (Figure 6E). CD25+ CD4+
cells from Foxp3cre; Slc3a2flox/flox mice showed a slight reduction
of ECAR at baseline and displayed a reduced increase of ECAR
after the addition of oligomycin, which blocks mitochondrial
ATP production. CD25+ CD4+ T cells were also analyzed for
the oxygen consumption rate (OCR), which indicates oxidativeight) of Foxp3+ CD4+ T cells in the spleens (n = 5 per group) of Slc3a2flox/flox and
ft: rTreg) and CD44highCD62Llow activated Treg cells (right: aTreg) in the spleen
r right) of Foxp3+ CD4+ T cells in the large intestines (LIs) (n = 6 per group) of
xp3+ Treg (left) and Helios Foxp3+ Treg cells (right) in the large intestines of
lls (left) and Foxp3 CD4+ T cells (right) derived from Slc3a2flox/flox or Foxp3cre;







Figure 6. Impaired Ile Responses in Slc3a2-Deficient Treg Cells
(A) CD25+ CD4+ cells and CD25 CD4+ cells from Slc3a2flox/flox or Foxp3cre; Slc3a2flox/flox mice were cultured for 12 hr without amino acids. Then, cells were
stimulated with 5 mM isoleucine (solid line), 5 mM leucine (dotted line), or PBS (gray histogram) for 20 min and analyzed for the phosphorylation of S6 ribosomal
protein (P-S6).
(B)Slc3a2flox/flox or Foxp3cre;Slc3a2flox/floxmicewere fed an isoleucine-reduced diet for 7 days and then reared with isoleucine-sufficient (Ile) or -reduced diets ()
for another 7 days. The number of Foxp3+ CD4+ T cells in the spleen is shown. Representative FACS dot plot (left), frequency (middle), and the cell number (right)
of splenic Foxp3+ CD4+ T cells in Slc3a2flox/flox or Foxp3cre; Slc3a2flox/flox mice (n = 5 per group) is shown. Each symbol represents an individual mouse, and the
means ± SD are indicated by horizontal bars.
(C) Intracellular BCAA concentrations of splenic CD25+ CD4+ Treg cells or CD25CD4+ T cells of Slc3a2flox/flox or Foxp3cre; Slc3a2flox/flox mice were measured by
liquid chromatography-tandem mass spectrometry (LC-MS/MS) system. The concentrations of amino acids were adjusted by the recovery rate of Phe-d5.
Ile, isoleucine; Leu, leucine; Val, valine.
(D) L-[14C] isoleucine uptake of splenic CD25+ CD4+ Treg cells from Slc3a2flox/flox mice or Foxp3cre; Slc3a2flox/flox mice was measured. Data are the means ± SEM
of 7 (Slc3a2flox/flox mice) or 6 (Foxp3cre; Slc3a2flox/flox mice) wells measurements and are representative data of two independent experiments.
(legend continued on next page)
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phosphorylation (Figure 6F). An increase in OCR by the addition
of carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone
(FCCP), which uncouples oxidative phosphorylation in mito-
chondria allowing maximal respiration, was decreased in
CD25+ CD4+ cells from Foxp3cre; Slc3a2flox/flox mice compared
to control cells. A previous report showed that altered metabolic
program in Rapter/ Treg cells correlated with the reduced
expression of genes involved in the lipogenic program, which
led to the impaired Treg cell function (Zeng et al., 2013). There-
fore, we analyzed expression of genes involved in cholesterol
biosynthesis, such as genes encoding 3-hydroxy-3-methylglu-
taryl-coenzyme A (CoA) reductase (HMGCR), 3-hydroxy-3-
methylglutaryl-CoA synthase 1 (HMGCS1) squalene epoxidase
(SQLE), and isopentenyl-diphosphate delta isomerase 1 (IDI1)
(Figure 6G). Expression of these genes was all reduced in
Slc3a2/ Treg cells. Thus, the metabolic program was compro-
mised in the absence of Slc3a2.
Defective Treg Cell Function in Treg-Cell-Specific
Slc3a2-Deficient Mice
Because Foxp3+ Treg cells in mice fed Ile-reduced diet had
defective suppressive functions, we analyzed the surface
expression of CTLA-4 and GITR and found that they were
decreased in Foxp3+ CD4+ splenic T cells from Foxp3cre;
Slc3a2flox/flox mice compared to control mice (Figure 7A). We
then analyzed the suppressive effect of Treg cells on T cell pro-
liferation (Figure S7). CD25+ CD4+ splenic T cells from control
mice suppressed co-cultured T cells in a cell-number-depen-
dent manner. However, the suppression of T cell proliferation
by CD25+ CD4+ splenic T cells from Foxp3cre; Slc3a2flox/flox
mice was impaired. In order to analyze the suppressive function
of Foxp3+ Treg cells more precisely, we generated Foxp3YFP-cre;
Slc3a2flox/flox mice (Rubtsov et al., 2008). We isolated YFP+
(Foxp3+) cells from Foxp3YFP-cre; Slc3a2+/+ and Foxp3YFP-cre;
Slc3a2flox/flox mice and analyzed for their suppressive activity
on CD4+ T cell proliferation (Figure 7B). YFP+ (Foxp3+) cells
from Foxp3YFP-cre; Slc3a2flox/flox mice did not suppress prolifera-
tion of CD4+ T cells. We then analyzed Treg cell suppressive ac-
tivity in vivo. We administered CD4+ CD45RBhigh T cells together
with CD4+ CD25+ cells from control (Slc3a2flox/flox) or Foxp3cre;
Slc3a2flox/flox mice into Rag2/ mice (Figures 7C–7E). Rag2/
mice transferred with CD4+ CD45RBhigh T cells developed
severe intestinal inflammation. Cotransfer of wild-type Treg cells
ameliorated colitis, but Slc3a2/ Treg cells did not. In accor-
dancewith severe intestinal pathology, the number of IFN-g-pro-
ducing CD4+ T cells was increased inmesenteric lymph nodes of
Rag2/ mice transferred with CD4+ CD45RBhigh T cells. The
number of IFN-g-producing CD4+ T cells was decreased by
cotransfer of wild-type, but not Slc3a2/, Treg cells (Figure 7E).(E and F) Extracellular acidification rate (ECAR) (E) and oxygen consumption rate (
Foxp3cre; Slc3a2flox/flox mice (open circle) were analyzed by XF-96 extracellula
oligomycin, FCCP, and antimycin A + rotenone (OCR). Data are the means ± SD o
representative of three independent experiments. 2-DG, 2-deoxy-D-glucose; FC
(G) qRT-PCR analysis of the lipogenic gene expression in freshly isolated splenic
antibody and IL-2 for 8 hr.
Data are the means ± SD of three well measurements. p values were determined b
****p < 0.001.
1834 Cell Reports 21, 1824–1838, November 14, 2017Thus, Treg cells of Foxp3cre; Slc3a2flox/flox mice showed a
defective suppressive activity. Furthermore, although Foxp3cre;
Slc3a2flox/flox mice seemed healthy, focal lymphocyte infiltration
was observed in many tissues, including the pancreas, thyroid,
stomach, liver, and salivary gland of aged (40–45 weeks old)
Foxp3cre; Slc3a2flox/flox mice (Figure 7F). Taken together, these
findings indicate that Slc3a2 is required for the function of Treg
cells.
DISCUSSION
Foxp3+ Treg cells are highly activated and proliferative in vivo.
IL-2 is a critical growth factor required for Treg cell expansion.
However, IL-2 cannot support Treg cell proliferation in vitro, indi-
cating the requirement of other factors for the maintenance of
Treg cells in vivo. Indeed, Treg cells require energy sources,
such as glucose, amino acids, and fatty acids, for their in vivo
maintenance (Newton et al., 2016; Procaccini et al., 2016).
Amino acids, particularly glutamine and Leu, mediate the differ-
entiation of Th1/Th17 cells and accordingly inhibit Foxp3+ Treg
cell differentiation (Klysz et al., 2015; Nakaya et al., 2014; Sinclair
et al., 2013). However, the involvement of amino acids in the
maintenance of differentiated Treg cells in vivo has not been
characterized, although the requirement of glucose for Treg
cell maintenance was suggested (Procaccini et al., 2016; Zeng
and Chi, 2015; Zeng et al., 2013). In the present study, we
demonstrated that BCAA controls the maintenance and function
of Treg cells in the periphery. Ile and Leu similarly induced the
phosphorylation of S6 in Treg cells and increased the number
of Treg cells in vivo, but Treg cell number reduced more severely
in mice fed Ile-reduced diet than mice fed Leu-reduced diet. In
this regard, in mice fed Leu-reduced or Val-reduced diet, serum
concentration of Ile was increased with unknown reason (unpub-
lished data). Therefore, it is possible that Ile, Leu, and Val
possess the similar activity on Treg cells and that the Leu or
Val insufficiency might be compensated with the increased Ile.
Alternatively, because the intracellular Ile concentration was
higher in Treg cells than Leu or Val, and the Ile level decreased
in Slc3a2/ Treg cells, Treg cells utilize Ile more preferentially
than Leu or Val. The precise comparison of Treg cell BCAA utili-
zation will be an interesting future issue to be addressed.
The mTOR pathway is involved in multiple T cell functions,
including differentiation, proliferation, survival, and gene activa-
tion, by sensing several cues in the environment, including amino
acid levels (Chi, 2012; Laplante and Sabatini, 2012; Thomson
et al., 2009). Accordingly, the mTOR pathway has been shown
to control Treg cell differentiation and functions depending on
the timing of mTORC1 activation (Procaccini et al., 2010).
Indeed, mTORC1 is activated by immune signals, such as IL-2OCR) (F) of splenic CD25+ CD4+ cells from either Slc3a2flox/flox (closed circle) or
r flux analyzer in the presence of glucose, oligomycin, and 2-DG (ECAR) or
f five (Slc3a2flox/flox) or six (Foxp3cre; Slc3a2flox/flox) well measurements and are
CP, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone.
CD25+ CD4+ Treg cells or those stimulated with anti-CD3 antibody/anti-CD28
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and TCR, leading to Treg cell activation via metabolic reprog-
ramming (Procaccini et al., 2010; Zeng and Chi, 2015). In freshly
isolated Treg cells exposed to many mTOR-activating environ-
mental cues in vivo, the mTOR pathway was activated as evi-
denced by the phosphorylation of S6 and p70S6K (Procaccini
et al., 2010 ; Zeng et al., 2013). However, the level of phosphor-
ylation of S6 and p70S6K was markedly reduced after 12 hr of
in vitro culture, in which mTOR-activating factors were absent.
In this setting, the addition of Ile or Leu induced the phosphory-
lation of S6 and p70S6K, indicating that BCAAs directly activate
the mTOR pathway in Treg cells. However, the BCAA-induced
phosphorylation of S6 and p70S6K in Treg cells was observed
at a low level. Currently, it is very hard to expand Treg cells
in vitro. The identification of factors in addition to BCAA, the
mixture of which effectively activates the mTOR pathway
in vitro, will enable the establishment of in vitro culture protocols
for Treg cell expansion.
The BCAA-mediated control of Treg cell maintenance and
function was dependent on the subunit of amino acid transporter
complexes, Slc3a2. Treg-cell-specific Slc3a2-deficient mice
showed similar Treg cell phenotypes to those in mice fed
Ile-reduced diet. Furthermore, Treg cells from Foxp3cre;
Slc3a2flox/flox mice showed defective Ile- and Leu-induced re-
sponses. Thus, Slc3a2 is required for the BCAA-dependent
maintenance and function of Treg cells in vivo. Slc3a2 forms
BCAA transporter complexes by associating with several
molecules, including Lat1, Lat2, y+Lat1, and y+Lat2 (Bodoy
et al., 2005; Kanai et al., 1998; Verrey et al., 2004). We analyzed
Foxp3cre; Slc7a5flox/flox mice (Treg-specific Lat1-deficient mice),
but the decrease of Treg cell numbers was only marginal and
those mutant mice did not show an inflammatory change in
any organs, indicating that molecules other than Slc7a5, which
associate with Slc3a2, also act as BCAA transporters on
Foxp3+ Treg cells (unpublished data).
The involvement of Slc3a2 on T cell functions has been studied
previously. These studies all focused on effector T cell differen-
tiation in vivo using Cd4cre or Lckcre mice, in which the targeted
gene was deleted at the early stage of T cell development in
the thymus (Bhuyan et al., 2014; Cantor et al., 2011; Kurihara
et al., 2015). In these mutant mice, the number of Foxp3+ Treg
cells was not reduced. Because Treg-cell-skewed in vitro condi-
tions induced the differentiation of naive CD4+ T cells into Treg
cells normally in the absence of Ile or Slc3a2, it is suspected
that the Ile/Slc3a2 axis is not involved in the Treg cell differenti-Figure 7. Defective Treg Cell Function in Treg-Cell-Specific Slc3a2-De
(A) Expression of CTLA-4 and GITR on splenic Foxp3+ CD4+ Treg cells from Slc3a
represent the isotype control.
(B) [3H]-thymidine uptake by CD4+ YFP T cells co-cultured with CD11c+ dendritic
Foxp3YFP-cre; Slc3a2+/+ mice (closed circle) or Foxp3YFP-cre; Slc3a2flox/flox mice (op
well measurements. p values were determined by Student’s t test. *p < 0.05; **p
(C–E) Rag2/ mice were transferred with CD4+ CD45RBhigh cells from Slc3a2
Slc3a2flox/flox mice or no Treg cells intraperitoneally. Body weight changes (per
Foxp3creSlc3a2flox/flox Treg cell group (closed square; n = 5), or no-Treg cell gro
sentative photos of H&E staining of colon sections. The scale bars represent 2
shown. Each symbol represents an individual mouse, and means ± SD are show
**p < 0.01.
(F) H&E staining of the pancreas, thyroid, stomach, liver, and salivary gland from
The scale bars represent 200 mm.
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(Lckcre); Slc3a2flox/flox mice and Foxp3cre; Slc3a2flox/flox mice
might be caused because the time point of Cre action is different
(in Cd4cre or Lckcre mice, Cre acts during T cell differentiation in
thymus, whereas in Foxp3cre mice, Cre works after Treg cell dif-
ferentiation). Because Slc3a2 is essential for the BCAA-medi-
ated maintenance of Treg cells, the Slc3a2 deficiency during
T cell differentiation might be compensated by other unknown
BCAA-sensing molecules in Cd4cre (Lckcre); Slc3a2flox/flox mice.
Similar to our results, Slc3a2/ Treg cells isolated from Cd4cre;
Slc3a2flox/flox mice were unable to prevent intestinal inflamma-
tion in Rag2/ mice transferred with naive T cells, indicating a
defect in the suppressive activity of Slc3a2/ Treg cells (Bhuyan
et al., 2014). Thus, previous studies also support our findings that
the Ile/Slc3a2 axis controls Treg cell functions.
In the large intestine, IL-10-producing pTreg cells are abun-
dantly present. It is noteworthy that the number of pTreg cells
rather than tTreg cells was reduced in the large intestine of
Foxp3cre; Slc3a2flox/flox mice. The mechanism by which intestinal
pTreg cells require more BCAA than tTreg cells would be an
interesting future issue to be addressed.
In conclusion, the present study demonstrates the importance
of the BCAA/Slc3a2 axis in the in vivomaintenance of Treg cells.
The proliferative potential of Treg cells is impaired in autoimmune
diseases, such as type I diabetes and multiple sclerosis (Car-
bone et al., 2014; Wing and Sakaguchi, 2010). It would be inter-
esting clinically to measure serum BCAA concentrations as well
as Treg cell numbers in patients with autoimmune diseases. The
supplementation of BCAAs might be useful for the treatment of
autoimmune diseases with decreased numbers of Treg cells.
EXPERIMENTAL PROCEDURES
Mice
BALB/c mice were purchased from Japan SLC. Foxp3 bicistronic reporter
knockin mice expressing EGFP (Foxp3-EGFP mice) on a C57BL/6J back-
ground and Rag2-deficient mice on a C57BL/6 background were purchased
from The Jackson Laboratory. Foxp3-IRES-Cre mice on a C57BL/6J
background were generated as described previously (Wing et al., 2008).
Foxp3YFP-Cre mice were generated as described previously (Rubtsov et al.,
2008). Slc3a2-floxed mice on a C57BL/6J background were generated previ-
ously (Liu et al., 2012). Mice deficient for Slc3a2 specifically in Foxp3+ Treg
cells (Foxp3cre; Slc3a2flox/flox) were generated by crossing Foxp3-IRES-Cre
mice with Slc3a2-floxed mice. The mice were used at 8–12 weeks old unless
otherwise noted. All animal experiments were conducted in accordance with
the guidelines of the Animal Care and Use Committee of Osaka University.ficient Mice
2flox/flox (solid line) or Foxp3cre; Slc3a2flox/flox mice (dotted line). Gray histograms
cells in the presence of increasing ratios of splenic CD4+ YFP+ Treg cells from
en circle). Data were expressed as CPM. Data are the means ± SD of triplicate
< 0.01.
flox/flox mice and CD25+CD4+ Treg cells from Slc3a2flox/flox mice or Foxp3cre;
cent of initial weight) of Slc3a2flox/flox Treg cell group (closed triangle; n = 6),
up (closed circle; n = 6) were shown. Data are the means ± SEM (C). Repre-
00 mm (D). Cell number of IFN-g+ CD4+ T cells in mesenteric lymph nodes is
n by horizontal bars (E). p values were determined by Mann-Whitney U test.
40- to 45-week-old Slc3a2flox/flox and Foxp3creSlc3a2flox/flox mice.
Diets
For amino-acid-reduced diet studies, 6-week-old BALB/cmicewere fedwith a
control diet or amino-acid-reduced diets, in which either valine, leucine, or
isoleucine was reduced by 90% (Oriental Yeast) for 2 weeks. In other experi-
ments, mice were fed with a standard Oriental MF diet (Oriental Yeast).
Flow Cytometry
PerCp/Cy5.5-conjugated anti-CD4 (GK1.5), phycoerythrin (PE)-conjugated
anti-mouse CD98 (RL388), PE-conjugated anti-mouse CX3CR1 (SA011F11),
PE-conjugated anti-mouse CD45RB (C363-16A), fluorescein isothiocyanate
(FITC)-conjugated anti-CD25 (7D4), FITC-conjugated anti-helios (22F6), PE/
Cy7-conjugated anti-GITR (YGITR765), PE/Cy7-conjugated anti-mouse
CD62L (MEL-14), FITC-conjugated anti-IFN-g (XMG1.2), Pacific-blue-conju-
gated anti-mouse/human CD44 (IM7), and Pacific-blue-conjugated anti-
mouse/human CD11b (M1/70) antibodies were purchased from BioLegend.
Pacific-blue-conjugated anti-Foxp3 (MF-14) antibody was purchased from
eBioscience. FITC-conjugated anti-CD103 (M290), PE-conjugated anti-
CD152 (UC10-4B9), Alexa-Fluor-647-conjugated anti-IL-17A (TC11-18H10.1),
PE-conjugated anti-IL-10 (JES5-16E3), and APC-conjugated anti-CD11c
(HL3) antibodies were purchased from BD Biosciences. FITC-conjugated
anti-CD98hc (RL388) antibody was purchased from Abcam. Alexa-Fluor-647-
conjugated anti-Foxp3 (3G3) antibody and anti-CD11c (N418) antibody were
purchased from Tonbo Bioscience. Single-cell suspensions were cultured for
4 hr in the presence of 5 mM calcium ionophore (Sigma-Aldrich), 50 ng/mL
phorbol 12-myristate 13-acetate (PMA) (Sigma-Aldrich), and Golgi Stop (BD
Biosciences), and intracellular cytokine expression was analyzed with a
Cytofix/Cytoperm plus kit with Golgi Stop according to the manufacturer’s
protocol (BD Biosciences). For Foxp3 staining, a Foxp3 Staining Buffer Set
(eBioscience) was used. For nuclear Ki-67 staining, the cells were fixed and
stained with anti-Ki-67-PE antibody (BD Biosciences) for 30 min at 4C. Flow
cytometric analysis was performed with a FACS Canto II flow cytometer (BD
Biosciences) with FlowJo software (Tree Star).
Histological Analysis
Tissues were fixed with 4% paraformaldehyde phosphate buffer solution
(Wako), and sections were stained with H&E (Wako). Slc3a2flox/flox and
Foxp3cre; Slc3a2flox/flox mice (40–45 weeks old) were used for the histological
study. Images were taken using BX53 microscope system (Olympus).
qRT-PCR
RNA preparation from samples was performed with TRIzol reagent (Life Tech-
nologies). After treatment with RQ1 DNase (Promega), total RNA was reverse
transcribed by Moloney Murine Leukemia Virus Reverse Transcriptase
(Promega) and random primers (Toyobo). cDNA was subjected to qPCR using
GoTaq qPCR Master Mix (Promega) in an ABI PRISM 7900HT sequence
detection system (Applied Biosystems). All values were normalized to the
expression ofGapdh. The following primer sets were used:Gapdh, 50-CCTCG
TCCCGTAGACAAAATG-30 and 50-TCTCCACTTTGCCACTGCAA-30; Slc3a2,
50-TGCTCAGGCTGACATTGTAGC-30 and 50-TCAGCCAAGTACAAGGGT
GC-30; Slc7a5, 50-TTGAAGGCACCAATCTGGACG-30 and 50-GGAGATGATGA
TGGCCAGGG-30; Slc7a8, 50-CTAGCCTCCAATGCAGTTGC-30 and 50-GGCT
CCAGCAAAGAACAGC-30; Slc43a1, 50-TTCACATGGTCTGGCCTGG-30 and
50-TGTGGTCCAAGGCTAACCC-30; Slc43a2, 50-ACAGTTTGGTAGCCTCACT
GG-30 and 50-CCGGTAGCAGATGAGGTAAAGG-30; Slc7a7, 50-ATGGGGGTG
TGACTTCAGC-30 and 50-CCAGGGTCCTGTGTTTGC-30; Slc7a6, 50-TACATC
CTGACCAACGTGGC-30 and 50-ATGCCGAATGTCTGGTCAGC-30; Slc6a14,
50-ATCCATTCCACTTGACCTCTG-30 and 50-GAAGTTTTTCGGCCAGGAC-30;
Slc6a19, 50-AAGGATGAGGAATGGGATCA-30 and 50-CTTCCCCTACCTATGC
CAGA-30; Hmgcr, 50-AGTCAGTGGGAACTATTGCAC-30 and 50-TTACGTCAA
CCATAGCTTCCG-30;Hmgcs1, 50-TGTTCTCTTACGGTTCTGGC-30 and 50-AA
GTTCTCGAGTCAAGCCTTG-30; Sqle, 50-TTGTTGCGGATGGACTCTTCTC
CA-30 and 50-GTTGACCAGAACAAGCTCCGCAAA-30; and Idi1, 50-GGTTCAG
CTTCTAGCGGAGA-30 and 50-TCGCCTGGGTTACTTAATGG-30.
Statistical Analysis
p valueswere calculatedwith Student’s t test or Mann-Whitney U test as spec-
ified in figure legends. Tukey-Kramer test was used to evaluate four groupswith JMP Pro 10 software (SAS Institute). p values < 0.05 were considered
significant.
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